Azacitidine

Related products

• 

  Melanoma

  Iplimma

  【Product name】Yervoy

  [English common name]Ipilimumab

  [Chinese common name]Iplimma

  [English name]

  [Chinese other name]

  [indications]Unresectable or metastatic adult malignancyMelanoma

  【Dosage】
  1. Unresectable or metastatic melanoma: 3 mg/kg, intravenously, once every 3 weeks, observe the infusion reaction for 90 minutes, up to 4 times. In the event of toxicity, the dose may be delayed, but all treatment must be performed within 16 weeks of the first dose.
  2. Adjuvant treatment of melanoma: 10 mg/kg, intravenous injection, once every 3 weeks, 4 times, and every 12 weeks thereafter, for 3 years. The infusion reaction was observed for 90 minutes, and if a toxic reaction occurred, the drug was stopped.
  3. Advanced renal cell carcinoma: 1 mg/kg, intravenously, once every 3 weeks, 4 times, observe the infusion reaction for more than 30 minutes, and then use Nawubumab alone.

  [Storage]Store at low temperature at 2 ° C - 8 ° C, do not freeze, protect the vial from light.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer

  Ixapilone

  【Product name】Ixempra

  [English common name]Ixabepilone

  [Chinese common name]Ixapilone

  [English name]Ipsapironum

  [Chinese other name]1-dioxide

  [Indications] IXEMPRA combined with capecitabine for the treatment of metastatic or local advancedBreast cancerPatients who are resistant to anthracyclines and taxanes, or whose cancers have taxane resistance and are further contraindicated for their anthracycline treatment. Anthracycline resistance is defined as the progressive metastatic environment during treatment or within 6 months or within 3 months of the adjuvant treatment group. Taxane resistance is defined as progression at treatment or within 12 months of adjuvant therapy or at 4 months in a metastatic environment.
  IXEMPRA is indicated for the treatment of advanced breast cancer anthracyclines, taxanes and capecitabine in patients with metastatic or local monotherapy tumor-resistant or refractory patients.

  [Usage and Dosage] The recommended dose of IXEMPRA is 40 mg / m 2 and intravenous administration for 3 hours every 3 weeks. The dose of a patient with a body surface area (BSA) greater than 2.2 m2 should be calculated according to 2.2 m2.

  [Storage] The IXEMPRA kit must be stored in a refrigerator at 2 ° C to 8 ° C (36 ° F to 46 ° F). Keep the original packaging until it is used to prevent light.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Breast cancer

  Pabotini

  【Product name】Ibrance

  [English common name]Palbociclib

  [Chinese common name]Pabotini

  [English name]

  [Chinese other name]

  [indications]Pabosini is a combination of estrogen receptor (ER) positive in women with postmenopausal women treated with letrozole, and negative for human epidermal growth factor receptor 2 (HER2)Breast cancerAs an initial endocrine-based treatment for kinase inhibitors in the treatment of metastatic disease.

  [Usage and Dosage] In combination with endocrine therapy, 125 mg is usually administered orally once a day to an adult as a parvociclib for 3 weeks, followed by withdrawal for 1 week. Repeat management with this loop. In addition, the weight is reduced according to the condition of the patient.

  [Storage] The drug does not require any special storage conditions.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Melanoma

  dabrafenib

  【Product name】Tafinlar

  [English common name]Dabrafenib

  [Chinese common name]dabrafenib

  [English name]

  [Chinese other name]

  [indications]
  1. Unremovable or transferred BRAF V600E gene mutantMelanoma(Not applicable to BRAF wild type melanoma).
  2. In combination with trimetiridine for the treatment of patients with unremovable or metastatic melanoma with BRAF V600E or V600K mutations.

  【Dosage】150 mg, orally, twice daily (12 hours apart), continued administration until disease progression or intolerable toxicity.
  1. Take 1 hour before meals or 2 hours after meals
  2. The lost dose can be taken 6 hours before the next dose, not within 6 hours from the next dose.
  3. Do not open, crush, or break the capsule

  [Storage] Store at 25 ° C (77 ° F); Allow 15 ° C to 30 ° C (59 ° F to 86 ° F)

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.